CLL (CHRONIC LYMPHOCYTIC LEUKEMIA)
Clinical trials for CLL (CHRONIC LYMPHOCYTIC LEUKEMIA) explained in plain language.
Never miss a new study
Get alerted when new CLL (CHRONIC LYMPHOCYTIC LEUKEMIA) trials appear
Sign up with your email to follow new studies for CLL (CHRONIC LYMPHOCYTIC LEUKEMIA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hard-to-treat blood cancers: experimental drug enters human testing
Disease control Recruiting nowThis early-phase study tests a new drug called ZE50-0134 in about 66 adults with chronic lymphocytic leukemia, small lymphocytic lymphoma, or certain low-grade lymphomas that have returned or not responded to prior therapies. The main goals are to check the drug's safety and how …
Matched conditions: CLL (CHRONIC LYMPHOCYTIC LEUKEMIA)
Phase: PHASE1 • Sponsor: Lomond Therapeutics Holdings, Inc. • Aim: Disease control
Last updated May 17, 2026 01:17 UTC
-
Could bone marrow from deceased donors treat blood cancers?
Disease control Recruiting nowThis early-phase study tests whether bone marrow from deceased donors can be safely used for people with blood cancers like leukemia and lymphoma. About 12 patients will receive a transplant after chemotherapy, and doctors will monitor for side effects and blood cell recovery for…
Matched conditions: CLL (CHRONIC LYMPHOCYTIC LEUKEMIA)
Phase: PHASE1, PHASE2 • Sponsor: Ossium Health, Inc. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New hope for Tough-to-Treat leukemia: phase 3 trial pits rocbrutinib against pirtobrutinib
Disease control Recruiting nowThis study tests a new drug, rocbrutinib, against another drug, pirtobrutinib, in people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back or not responded to prior treatments. About 306 adults will take one of the two pills daily to s…
Matched conditions: CLL (CHRONIC LYMPHOCYTIC LEUKEMIA)
Phase: PHASE3 • Sponsor: Newave Pharmaceutical Inc • Aim: Disease control
Last updated May 11, 2026 20:51 UTC
-
New drug cocktails aim to tame transplant complications in blood cancer patients
Disease control Recruiting nowThis study tests new drug combinations to prevent graft-versus-host disease (GVHD) in people with blood cancers who receive stem cells from an unrelated donor. About 358 participants will get either the standard GVHD prevention drugs or a new mix, and researchers will compare whi…
Matched conditions: CLL (CHRONIC LYMPHOCYTIC LEUKEMIA)
Phase: PHASE2 • Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control
Last updated May 11, 2026 20:41 UTC
-
Plant-Based diet trial aims to slow Early-Stage leukemia
Disease control Recruiting nowThis study looks at whether a 4-week whole-food, plant-based diet can change how the immune system works and slow disease activity in people with early-stage chronic lymphocytic leukemia (CLL) who have not yet had treatment. Researchers will measure blood cell counts and study im…
Matched conditions: CLL (CHRONIC LYMPHOCYTIC LEUKEMIA)
Phase: NA • Sponsor: Technical University of Munich • Aim: Disease control
Last updated May 04, 2026 16:20 UTC
-
No treatment, just watching: new study tracks blood cancer over years
Knowledge-focused Recruiting nowThis study follows up to 1,000 adults with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), Waldenstrom macroglobulinemia, or related conditions to learn how these diseases progress over time. Participants receive no treatment as part of the study; instead, t…
Matched conditions: CLL (CHRONIC LYMPHOCYTIC LEUKEMIA)
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC